NCT02668341Unknown不适用
PsoBarrierEU - Barrier Analysis of Guideline-Compliant Healthcare for Psoriasis in Europe
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 1,304
- 试验地点
- 4
- 主要终点
- Percentage of patients with severe disease receiving systemic treatment
研究概览
简要总结
Analysis of barriers in psoriasis care from the patient's and the physician's perspective and generation of scientific data on the quality of health care in Denmark, Poland, Spain, and Germany
详细描述
Cross-sectional, non-interventional study on healthcare for psoriasis in patients and their treating physicians. Clinical data on severity as well as subjective estimates on disease burden, quality of life etc. will be collected. Data collection is planned at multiple, representative sites in fourEuropean countries with different healthcare systems with the aim to identify system-dependent and -independent barriers in guideline-compliant psoriasis care.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •clinically diagnosed psoriasis vulgaris
- •written informed consent
排除标准
- •lack of mental, physical or linguistic ability to participate in a questionnaire survey
结局指标
主要结局
Percentage of patients with severe disease receiving systemic treatment
时间窗: Baseline
次要结局
- Body Surface Area (BSA)(Baseline)
- Dermatology Life Quality Index (DLQI)(Baseline)
- Percentage of patients with comorbidities receiving treatment.(Baseline)
- Psoriasis Area and Severity Index (PASI)(Baseline)
- EuroQuol (EQ-5D)(Baseline)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Clinical Assessment and Psychosocial Impact of PsoriasisPsoriasisNCT01964443Janssen Pharmaceutica N.V., Belgium719
已完成
不适用
A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)Moderate Plaque PsoriasisNCT03059953Genesis Pharma S.A.302
已完成
不适用
Developing diagnostic criteria for psoriasis in childrePsoriasis in children and young peopleSkin and Connective Tissue DiseasesPsoriasisISRCTN98851260niversity of Nottingham348
已完成
不适用
Management of psoriasis and risk and severity of COVID-19 infection in systemic, biologic and topical treatment for psoriasis during the COVID-19 pandemic: an epidemiological cohort studyPsoriasis1004743810014982NL-OMON51144Bravis Ziekenhuis1,500
已完成
不适用
Treatment Goals in Psoriatic ArthritisPsoriatic ArthritisNCT03620188Johns Hopkins University250